AlphaYouTT
Congress trade
Sen. Thomas Tuberville (R-AL) sold $1K-$15K of AbbVie Inc. (ABBV) stock
Thomas Tuberville, U.S. Senator (R-AL), disclosed a sale of AbbVie Inc. (ABBV) stock worth $1K-$15K in a STOCK Act filing on Feb 14, 2022.
The trade happened on Jan 21, 2022, 24 days before it was made public.
ABBV has moved +99.2% since the trade date, from $131.98 to $262.90 (Oct 2, 2026 close).
- Traded
- Jan 21, 2022
- Disclosed
- Feb 14, 2022
- Filing delay
- 24 days
- Price since
- +99.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (59)
- BuyBABA$50K-$100KFeb 14, 2022
- BuyGOLD$50K-$100KFeb 14, 2022
- SellAAPL$15K-$50KFeb 14, 2022
- SellABC$15K-$50KFeb 14, 2022
- SellABQCX$15K-$50KFeb 14, 2022
- SellACN$15K-$50KFeb 14, 2022
- SellADBE$15K-$50KFeb 14, 2022
- SellAWK$15K-$50KFeb 14, 2022
- BuyBABA$15K-$50KFeb 14, 2022
- BuyBABA$15K-$50KFeb 14, 2022
- SellCLOU$15K-$50KFeb 14, 2022
- SellCRWD$15K-$50KFeb 14, 2022
- SellCTAS$15K-$50KFeb 14, 2022
- SellCTAS$15K-$50KFeb 14, 2022
- SellDUK$15K-$50KFeb 14, 2022
- SellFGSCX$15K-$50KFeb 14, 2022
- SellFUN$15K-$50KFeb 14, 2022
- BuyINTC$15K-$50KFeb 14, 2022
- SellLLY$15K-$50KFeb 14, 2022
- SellLMT$15K-$50KFeb 14, 2022
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.